IP Library Granted Patent US 8,709,781
Granted Patent B2
US 8,709,781 · App. 12/565,314 · Granted Apr 29, 2014

System and method for the heterologous expression of polyketide synthase gene clusters

Inventors: Christopher N. Boddy (Ottawa, CA); Anthony Garza (Syracuse, NY)
Assignee: Syracuse University
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,709,781
App. No.
12/565,314
Granted
Apr 29, 2014
Kind
B2
Abstract

A system and method for heterologous expression of polyketide biosynthetic pathways from streptomycetes hosts in Escherichia coli for the production and discovery of secondary metabolites. Genomic DNA from Streptomyces rimosus encoding the oxytetracycline biosynthetic pathway is inserted into the genome of the surrogate host Myxococcus xanthus . The M. xanthus transcriptional machinery recognizes and uses the streptomycetes promoter regions to express the biosynthetic enzymes. Co-expression in E. coli of S. rimosus oxytetracycline biosynthesis enzymes and M. xanthus σ 54 , a key piece of the M. xanthus transcriptional machinery, enables E. coli to recognize and use the promoters from the S. rimosus oxytetracycline biosynthetic pathway, facilitating production of oxytetracycline.

Claims (9)

1. A genetically modified host organism for expressing a target polyketide, comprising:

a first modification comprising the addition of a non-native gene cluster that encodes for the target polyketide biosynthetic pathway;

a second modification comprising the addition of an rpoN gene from Myxococcus xanthus ; and

a third modification comprising the addition of an inducible promoter positioned upstream of and operatively associated with the rpoN gene added to said host organism.

2. The organism of claim 1 , further comprising a gene encoding an RNA polymerase.

3. The organism of claim 1 , wherein the organism is at least one organism selected from the group consisting of Escherichia coli, Streptomyces rimosus, Streptomyces lividans, Streptomyces coelicolor Myxococcus xanthus, Pseudomonas putida , and Bacillus subtilis.

4. The organism of claim 1 , wherein the rpoN gene comprises SEQ. ID. No. 1.

5. The organism of claim 1 , wherein the promoter comprises a T7 promoter.

6. The organism of claim 1 , wherein the target polyketide comprises oxytetracycline.

Assignments (2)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Sep 23, 2009
From: BODDY, CHRISTOPHER N.
To: SYRACUSE UNIVERSITY
Reel/Frame 023274/0255 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Sep 23, 2009
From: GARZA, ANTHONY
To: SYRACUSE UNIVERSITY
Reel/Frame 023274/0300 →
Continuity (2)
Provisional Application 61143547 · Jan 9, 2009
Related Publication 20100184038A1 · Jul 22, 2010